Gut Microbiome, Short-chain Fatty Acids, Alpha-synuclein, Neuroinflammation, and ROS/RNS: Relevance to Parkinson's Disease and Therapeutic Implications
Overview
Affiliations
In this review, we explore how short-chain fatty acids (SCFAs) produced by the gut microbiome affect Parkinson's disease (PD) through their modulatory interactions with alpha-synuclein, neuroinflammation, and oxidative stress mediated by reactive oxygen and nitrogen species (ROS/RNS). In particular, SCFAs-such as acetate, propionate, and butyrate-are involved in gut-brain communication and can modulate alpha-synuclein aggregation, a hallmark of PD. The gut microbiome of patients with PD has lower levels of SCFAs than healthy individuals. Probiotics may be a potential strategy to restore SCFAs and alleviate PD symptoms, but the underlying mechanisms are not fully understood. Also in this review, we discuss how alpha-synuclein, present in the guts and brains of patients with PD, may induce neuroinflammation and oxidative stress via ROS/RNS. Alpha-synuclein is considered an early biomarker for PD and may link the gut-brain axis to the disease pathogenesis. Therefore, elucidating the role of SCFAs in the gut microbiome and their impact on alpha-synuclein-induced neuroinflammation in microglia and on ROS/RNS is crucial in PD pathogenesis and treatment.
Wang W, Shi S, Su M, Li Y, Yao X, Jiang J Probiotics Antimicrob Proteins. 2025; .
PMID: 40048129 DOI: 10.1007/s12602-025-10499-1.
Chen X, Wei J, Zhang L, Wang H, Zhang Y, Li Z Lipids Health Dis. 2025; 24(1):66.
PMID: 39984934 PMC: 11846350. DOI: 10.1186/s12944-025-02477-x.
The dual role of PGAM5 in inflammation.
Qi Y, Rajbanshi B, Hao R, Dang Y, Xu C, Lu W Exp Mol Med. 2025; 57(2):298-311.
PMID: 39930129 PMC: 11873181. DOI: 10.1038/s12276-025-01391-7.
Shan J, Li Z, Ji M, Zhang M, Zhang C, Zhu Y Front Aging Neurosci. 2025; 16:1498176.
PMID: 39877075 PMC: 11772336. DOI: 10.3389/fnagi.2024.1498176.
Microbiome-based therapies for Parkinson's disease.
Alam M, Abbas K, Mustafa M, Usmani N, Habib S Front Nutr. 2024; 11:1496616.
PMID: 39568727 PMC: 11576319. DOI: 10.3389/fnut.2024.1496616.